Jaguar Health, Inc. (JAGX)

Jaguar Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	10.14	9.76	11.96	4.34	9.39	5.78
Revenue Growth (YoY)	-10.29%	-18.36%	175.80%	-53.81%	62.51%	30.77%
Cost of Revenue	2.12	2.04	2.02	2.33	3.28	3.82
Gross Profit	8.02	7.72	9.94	2	6.11	1.96
Selling, General & Admin	22.18	23.05	26.71	26	21	20.44
Research & Development	18.13	18.6	17.65	15.08	6.41	5.82
Other Operating Expenses	0.39	0.37	0	1.63	5.34	4.65
Operating Expenses	40.69	42.02	44.35	42.71	32.75	30.91
Operating Income	-32.68	-34.29	-34.42	-40.71	-26.65	-28.95
Interest Expense / Income	4.81	6.38	12.72	8.42	2.79	5.73
Other Expense / Income	0.84	0.63	0.32	3.47	4.37	3.85
Pretax Income	-38.32	-41.3	-47.45	-52.6	-33.81	-38.53
Income Tax	0	0	0	0	0	0.01
Net Income	-38.32	-41.3	-47.45	-52.6	-33.81	-38.54
Preferred Dividends	0	0	0	0	4.84	6.19
Net Income Common	-38.32	-41.3	-47.45	-52.6	-38.65	-44.73
Shares Outstanding (Basic)	3	0	0	0	0	0
Shares Outstanding (Diluted)	3	0	0	0	0	0
Shares Change	3008.70%	1658.88%	120.00%	247.17%	677.72%	2200.00%
EPS (Basic)	-42.60	-107.40	-2170.80	-5293.20	-13500.34	-121639.26
EPS (Diluted)	-26.40	-107.40	-2170.80	-5293.20	-13500.34	-121639.26
Free Cash Flow	-30.34	-33.24	-33.18	-34.98	-15.29	-20.46
Free Cash Flow Per Share	-11.46	-86.46	-1517.98	-3520.16	-5340.03	-55621.41
Gross Margin	79.07%	79.13%	83.11%	46.18%	65.05%	33.92%
Operating Margin	-322.24%	-351.31%	-287.85%	-939.05%	-283.93%	-501.26%
Profit Margin	-377.95%	-423.11%	-396.91%	-1213.26%	-411.81%	-774.48%
Free Cash Flow Margin	-299.25%	-340.56%	-277.53%	-806.83%	-162.87%	-354.23%
EBITDA	-31.07	-32.53	-32.44	-42.36	-28.74	-30.87
EBITDA Margin	-306.36%	-333.27%	-271.32%	-977.19%	-306.20%	-534.55%
Depreciation & Amortization	2.45	2.39	2.29	1.81	2.28	1.93
EBIT	-33.51	-34.92	-34.73	-44.17	-31.02	-32.8
EBIT Margin	-330.49%	-357.73%	-290.49%	-1019.01%	-330.50%	-567.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).